After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Day One Biopharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Day One Biopharmaceuticals Inc is $1.26B. A total of 0.57 million shares were traded on the day, compared to an average of 986.68K shares.
In the most recent transaction, Blackman Samuel C. sold 30,000 shares of DAWN for 14.22 per share on Sep 10 ’24. After the transaction, the HEAD OF R&D now owns 1,097,535 company shares. In a previous transaction on Aug 16 ’24, Dubow Adam sold 3,202 shares at 14.00 per share. DAWN shares that GENERAL COUNSEL owns now total 26,928.
Among the insiders who sold shares, York Charles N II disposed of 2,633 shares on Aug 16 ’24 at a per-share price of $14.00. This resulted in the COO, CFO AND SECRETARY holding 232,485 shares of DAWN after the transaction. In another insider transaction, Blackman Samuel C. sold 2,232 shares at $14.00 per share on Aug 16 ’24. Company shares held by the HEAD OF R&D now total 1,127,535.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, DAWN has a high of $18.07 and a low of $9.67.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. DAWN’s latest balance sheet shows that the firm has $284.31M in Cash & Short Term Investments as of fiscal 2021. There were $220.00k in debt and $8.66M in liabilities at the time. Its Book Value Per Share was $3.50, while its Total Shareholder’s Equity was $281.15M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DAWN is Buy with a score of 4.70.
